Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders

Lipid metabolic disorders have become a major global public health concern. Fatty liver and dyslipidemia are major manifestations of these disorders. Recently, MicroRNA-33 (miR-33), a post-transcriptional regulator of genes involved in cholesterol efflux and fatty acid oxidation, has been considered...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Yaoye, Xu, Shengjun, Wang, Jianguo, Xu, Li, Zhang, Chenzhi, Chen, Kangchen, Lian, Zhengxing, Zhou, Junbin, Xie, Haiyang, Zheng, Shusen, Xu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419650/
https://www.ncbi.nlm.nih.gov/pubmed/32848718
http://dx.doi.org/10.3389/fphar.2020.00921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419650/
https://www.ncbi.nlm.nih.gov/pubmed/32848718
http://dx.doi.org/10.3389/fphar.2020.00921

Ejemplares similares